Source link : https://www.newshealth.biz/health-news/high-hopes-and-costs-low-uptake/
Gene therapy has been available since 2022 for hemophilia B and since 2023 for hemophilia A, yet some major medical institutions have barely treated any patients so far. What’s the holdup? Hematologists said that a range of factors could explain the slow uptake of a potentially life-transforming treatment. It’s tremendously expensive, for one thing, although […]
Author : News Health
Publish date : 2025-01-16 09:07:04
Copyright for syndicated content belongs to the linked Source.